FSRH overweight, obesity, and contraception guideline
Covering evidence-based recommendations on the provision of contraception to women who are overweight or obese
NICE antenatal care guideline
Covering the organisation and delivery of antenatal care, including the involvement of partners
PHE inadvertent vaccination in pregnancy guideline
This concise and useful summary covers monitoring of women vaccinated in pregnancy or shortly before conception
NICE heavy menstrual bleeding guideline
Includes recommendations on management and investigations on the causes of heavy menstrual bleeding, also covering history taking, diagnosis, and provision of information
NICE postnatal feeding guidance
A summary of guidance on planning and supporting babies’ feeding in the first 8 weeks after the birth taken from the NICE guideline on postnatal care
NICE postnatal care guideline
A concise summary on the routine postnatal care that women and their babies should receive in the first 8 weeks after the birth
GAIN (RQIA) admission to midwife-led units in Northern Ireland
A summary of recommendations for planning place of birth in Northern Ireland, giving detail of the normal labour and birth care pathway
FSRH progestogen-only implant guideline
A summary of guidance relating to the etonogestrel subdermal contraceptive implant
RCN nurse specialist in menopause guidance
This summary outlines the role of the nurse specialist in menopause, including guidance on the required clinical practice skills and service provision
NICE diabetes in pregnancy guideline
An up-to-date summary of NICE guidance on diabetes management in pregnancy. Includes gestational diabetes, preconception, antenatal, and postnatal care.
Resource hub
Making the case for preconception care
Having a smear test—what is it about?
Human papillomavirus (HPV) vaccination and cervical cancer—addressing the myths
Your guide to staying active in pregnancy
Pain and symptom diary
- Previous
- Next
Educational resources
Osteoporotic fracture guideline
This guideline was developed by a multidisciplinary expert panel: Cooper C et al with the support of an educational grant from UCB Pharma Ltd.
Women of child-bearing age with inflammatory rheumatic diseases guideline
This guideline was developed by a multidisciplinary expert panel: Giles I et al with the support of an educational grant from UCB Pharma Ltd.
The importance of the progestogenic component of hormone replacement therapy in women with a uterus
Dr John Stevenson and Dr Sophia Tsiligiannis discuss progestogen prescribing in hormone replacement therapy.
Uncomplicated recurrent UTI guideline
This guideline was developed by a multidisciplinary expert panel: Rees J et al with the support of a grant from Aspire Pharma Ltd.